ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.913,01
0,00%
S&P 500
6.083,57
0,36%
Dow Jones
44.747,63
-0,28%
Euro vs US Dollar
1,03889
0,03%
Bitcoin
96.903,60
0,34%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX

  6. Eupraxia Pharmaceuticals Inc (EPRX) Börsenkurse

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
4,49
0,10
(2,28%)
Geschlossen 07 Februar 10:12PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
4,49
Gebot
4,48
Fragen
4,49
Volumen
6.500
4,37 Tagesbereich 4,49
3,07 52-Wochen-Bereich 7,64
Marktkapitalisierung
122,496M
Handelsende
4,39
Handelsbeginn
4,40
Letzte Trade
100
@
4.49
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
16.318
Ausgegebene Aktien
27.282.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,34
Gewinn pro Aktie (EPS)
-1,03
Erlöse
-
Nettogewinn
-28,22M

Über Eupraxia Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Hauptsitz
Victoria, British Columbia, Can
Gegründet
-
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $4,39. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 3,07 to $ 7,64.

Eupraxia Pharmaceuticals currently has 27.282.000 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is $119,77 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.34.

EPRX Neueste Nachrichten

Weitere Nachrichten

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...

20 November 2024
PR Newswire (US)

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...

14 November 2024
PR Newswire (US)

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

13 November 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis PR Newswire VICTORIA, BC, Nov. 12, 2024 One...

12 November 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...

07 November 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million PR Newswire VICTORIA, BC, Oct. 31, 2024 VICTORIA, BC, Oct. 31, 2024 /PRNewswire/...

01 November 2024
PR Newswire (US)

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024 PR Newswire VICTORIA, BC, Oct. 28, 2024 VICTORIA, BC, Oct. 28, 2024 /PRNewswire/...

28 Oktober 2024
PR Newswire (US)

Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR for the Treatment of Knee Osteoarthritis

Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR for the Treatment of Knee Osteoarthritis PR Newswire VICTORIA, BC, Oct. 15, 2024 Publication...

15 Oktober 2024
PR Newswire (US)

Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024

Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024 PR Newswire VICTORIA, BC, Oct. 10, 2024 VICTORIA, BC, Oct. 10, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...

10 Oktober 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Strengthens Senior Management Team

Eupraxia Pharmaceuticals Strengthens Senior Management Team PR Newswire VICTORIA, BC, Oct. 2, 2024 VICTORIA, BC, Oct. 2, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or...

02 Oktober 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.194.418604651164.34.494.13211274.40207944CS
40.255.896226415094.244.74.13134094.41769429CS
120.4410.86419753094.055.454.01163184.59557478CS
260.8423.01369863013.655.453.07229224.07192789CS
52-1.61-26.3934426236.17.643.07321794.24216905CS
1562.48123.3830845772.019.10.8276384.31573963CS
260-3.26-42.0645161297.759.10.8245874.23355108CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals share price?
The current share price of Eupraxia Pharmaceuticals is $ 4,49
How many Eupraxia Pharmaceuticals shares are in issue?
Eupraxia Pharmaceuticals has 27.282.000 shares in issue
What is the market cap of Eupraxia Pharmaceuticals?
The market capitalisation of Eupraxia Pharmaceuticals is CAD 119,77M
What is the 1 year trading range for Eupraxia Pharmaceuticals share price?
Eupraxia Pharmaceuticals has traded in the range of $ 3,07 to $ 7,64 during the past year
What is the PE ratio of Eupraxia Pharmaceuticals?
The price to earnings ratio of Eupraxia Pharmaceuticals is -4,34
What is the reporting currency for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals reports financial results in USD
What is the latest annual profit for Eupraxia Pharmaceuticals?
The latest annual profit of Eupraxia Pharmaceuticals is USD -28,22M
What is the registered address of Eupraxia Pharmaceuticals?
The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.
What is the Eupraxia Pharmaceuticals website address?
The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com
Which industry sector does Eupraxia Pharmaceuticals operate in?
Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ACBAurora Cannabis Inc
$ 8,95
(16,99%)
3,28M
GRCGold Springs Resource Corp
$ 0,07
(16,67%)
55k
DIAMStar Diamond Corporation
$ 0,04
(14,29%)
294,8k
DLCGDominion Lending Centres Inc
$ 8,50
(13,33%)
32,67k
THTheratechnologies Inc
$ 2,44
(11,93%)
205,43k
BNGBengal Energy Ltd
$ 0,005
(-50,00%)
42k
MDPMedexus Pharmaceuticals Inc
$ 3,05
(-19,53%)
608,95k
RTGRTG Mining Inc
$ 0,025
(-16,67%)
33k
KRNKarnalyte Resources Inc
$ 0,085
(-15,00%)
20,72k
AVLAvalon Advanced Materials Inc
$ 0,03
(-14,29%)
1,6k
SUSuncor Energy Inc
$ 54,99
(-0,81%)
12,94M
ENBEnbridge Inc
$ 63,26
(0,41%)
12,91M
MFCManulife Financial Corporation
$ 42,92
(0,42%)
11,32M
WEEDCanopy Growth Corporation
$ 3,99
(9,32%)
6,99M
POUParamount Resources Ltd
$ 31,41
(0,96%)
6,63M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSX
EPRX
Eupraxia Pharmaceuticals
BOV
TRPL-DEB710B
ISA CTEEP
BOV
IBEP
Indice Bovespa B3 Empres...
BIT
FCYBER
Vontobel
BOV
ITUBL280
ITUBL280 Ex:27,98
BOV
TJXC34R
TJX Companies
BIT
I06574
Banca Imi
BIT
I06586
Banca Imi
BOV
M1HK34M
Mohawk Industries
LSE
0DT2
First Trust Eurozone Alp...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten